How to Buy Coeptis Therapeutics Holdings Stock

Coeptis Therapeutics Holdings Inc

Coeptis Therapeutics Holdings is a biotech company located in Pennsylvania, United States, which is part of the Healthcare sector, and is traded under the ticker COEP on the NASDAQ exchange.

Coeptis Therapeutics Holdings stock last closed at $9.92, up 10.59% from the previous day, and has increased 48.1% in one year. It has overperformed other stocks in the Biotechnology industry by 1.25 percentage points. Coeptis Therapeutics Holdings stock is currently +329.44% from its 52-week low of $2.31, and -27.59% from its 52-week high of $13.70.

At the moment, there are 3.36M COEP shares outstanding. The market capitalization of COEP is $33.38M. In the last 24 hours, 287,170 COEP shares were traded.

How to Buy Coeptis Therapeutics Holdings Stock

Not sure how to invest in Coeptis Therapeutics Holdings stock? Here's how.

  1. Choose where to buy Coeptis Therapeutics Holdings stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you decide where to buy Coeptis Therapeutics Holdings stock.
  2. Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Fund your investment account: Choose your payment method and add your info.
  4. Analyze Coeptis Therapeutics Holdings stock: The Coeptis Therapeutics Holdings ticker symbol is COEP. Is Coeptis Therapeutics Holdings stock a good investment? Should you buy shares of COEP? How do COEP's underlying business fundamentals look? Do top analysts think Coeptis Therapeutics Holdings is a good buy? Why has COEP's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if COEP is a good stock to buy).
  5. Make your COEP trade: Decide if you will purchase COEP shares at the current market price or use a limit order to buy COEP stock at a given price.
  6. Keep tabs on your investment in COEP: Create a watchlist to the latest updates on your new investment in Coeptis Therapeutics Holdings shares.

Step 1: Choose where to buy Coeptis Therapeutics Holdings stock

You will need a brokerage account to access the NASDAQ market and buy COEP shares.

A brokerage account allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our experience, eToro is the best online stock brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to world financial markets: From Technology to Industrials, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've selected the best brokerage, the next step is to fill out some personal details so you are able to invest in COEP stock today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal data to create a new brokerage account.
  1. Send your information by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you have filled out your info on stock market app, you can securely and quickly fund your account:

Watch this video walkthrough for more details transferring money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Coeptis Therapeutics Holdings stock

Once you have figured out the best place to buy Coeptis Therapeutics Holdings stock, it's crucial to analyze their stock before you invest, so you can wrap your head around the risk as well as the opportunity.

Coeptis Therapeutics Holdings Numbers

COEP Price
$9.92
1w %
-14.48%
1y %
48.1%
5y %
N/A
P/E
-1.76x
P/B
10.48x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$9.81M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$33.38M
Next Earnings
N/A
Next Dividend
N/A

COEP Overview

WallStreetZen was created to help average investors perform more in-depth fundamental analysis.

You can view all of the due diligence checks on COEP's stock page.

Is COEP stock properly valued?

You can use many financial metrics, analyses, models, and charts to gauge COEP's fair value.

Using relative valuations measures:

  • COEP may be overvalued based on its P/B ratio of 10.48x, relative to Biotechnology industry P/B ratio of 4.37x

You can access additional valuation analysis on COEP's stock here.

Is COEP a healthy company?

Pros:

  • There are more short-term assets than long-term liabilities on the COEP balance sheet.
  • Total COEP debt is lower than 5 years ago, relative to shareholder equity.

Cons:

  • COEP has $532.89k in cash and short term investments. This is not sufficient to cover its annual cash burn of $6.65M.
  • There are more short-term liabilities than short-term assets on the COEP balance sheet.
  • COEP has a relatively high debt to equity ratio of 1.58.
  • COEP has cash burn of 6649281. It does not have enough cash and short-term investments to cover this.

You can dig deeper into what analysts are projecting on the Coeptis Therapeutics Holdings stock forecast page.

COEP Momentum

SMA10
10.2
SMA20
9.82
SMA50
10.13
SMA100
8.86
SMA200
6.5
MACD
0.03
MACD Signal
0.06
MACD Histogram
-0.02
RSI
49.91
Stochastic %K
41.72
Stochastic %D
56.2
StochRSI %K
18.7
StochRSI %D
41.26

COEP Performance Metrics

Last year, COEP revenue was $0.00. During the past four year, COEP's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 45.47%.

You can analyze COEP's earnings and revenue performance here.

Are COEP executives and large shareholders buying or selling the stock?

Over the last year, insiders at COEP have not bought or sold any shares.

Learn more about who owns COEP shares here.

Can I get consistent income from COEP stock?

No, Coeptis Therapeutics Holdings doesn't provide an income stream by paying out dividends.

What others are saying about COEP

One of the primary reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Make your COEP trade

You have two main options:

  • Market order: A market order is an order to buy or sell a security at the best available price.
    Market orders are mostly fine for most investors.
  • Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at a specific price, place a limit order.

Hit the Open Trade button and your broker will place your order.

If you require additional assistance investing in stocks on eToro, watch the helpful video below:

Open eToro Account

Step 6: Keep tabs on your investment in COEP

Now that you own some COEP stock, you'll want to stay up-to-date on your new shares.

Create a watchlist to track your COEP stock.

COEP Feed

How to Buy Stock in Coeptis Therapeutics Holdings

To reiterate, here are the 6 steps to buy stock in Coeptis Therapeutics Holdings:

  1. Choose where to buy Coeptis Therapeutics Holdings stock
  2. Create your brokerage account
  3. Fund your investment account
  4. Analyze Coeptis Therapeutics Holdings stock
  5. Make your COEP trade
  6. Keep tabs on your investment in COEP

If you need a online brokerage, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to get updates on your new investment in Coeptis Therapeutics Holdings, hit the button below to create your watchlist.

NASDAQ: COEP
$9.92+0.95 (+10.59%)
Updated Apr 29, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: COEP
$9.92+0.95 (+10.59%)
Updated Apr 29, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Coeptis Therapeutics Holdings share?

As of Apr 29, 2025, it costs $9.92 to buy one share of Coeptis Therapeutics Holdings stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $4, you can buy 0.403 shares of COEP.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

What is the best way to buy Coeptis Therapeutics Holdings stock?

One way to place an order for Coeptis Therapeutics Holdings stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.